Stock Events

Stock Events

Edwards Lifesciences 

$81.81
265
-$2.81-3.32% Friday 19:59

Statistics

Day High
85.33
Day Low
81.35
52W High
87.89
52W Low
65.94
Volume
4,498,504
Avg. Volume
4,278,606
Mkt Cap
47.52B
P/E Ratio
36
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.55
0.61
0.67
0.73
Expected EPS
0.727915
Actual EPS
N/A

Financials

17.5%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
12.27BRevenue
2.15BNet Income

Analyst Ratings

$97.53Average Price Target
The highest estimate is 110.00.
From 19 ratings within the last 6 months. This is not an investment recommendation.
Buy
68%
Hold
32%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EW. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap136.19B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap9.49B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

About

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Show more...
CEO
Mr. Bernard J. Zovighian
Employees
15800
Country
US
ISIN
US28176E1082

Listings

MX
MX
EW.MX
LSE
GB
0REN.LSE
MI
IT
1EW.MI
VI
AT
EWLS.VI

0 Comments

Share your thoughts

FAQ

What is Edwards Lifesciences stock price today?▼
The current price of EW is $81.81 USD — it has decreased by -3.32% in the past 24 hours. Watch Edwards Lifesciences stock price performance more closely on the chart.
What is Edwards Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Edwards Lifesciences stocks are traded under the ticker EW.
Is Edwards Lifesciences stock price growing?▼
EW stock has risen by +0.21% compared to the previous week, the month change is a +7.83% rise, over the last year Edwards Lifesciences has showed a +18.07% increase.
What is Edwards Lifesciences market cap?▼
Today Edwards Lifesciences has the market capitalization of 47.52B
When is the next Edwards Lifesciences earnings date?▼
Edwards Lifesciences is going to release the next earnings report on April 29, 2026.
What were Edwards Lifesciences earnings last quarter?▼
EW earnings for the last quarter are 0.58 USD per share, whereas the estimation was 0.62 USD resulting in a -6.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Edwards Lifesciences revenue for the last year?▼
Edwards Lifesciences revenue for the last year amounts to 12.27B USD.
What is Edwards Lifesciences net income for the last year?▼
EW net income for the last year is 2.15B USD.
How many employees does Edwards Lifesciences have?▼
As of March 15, 2026, the company has 15,800 employees.
In which sector is Edwards Lifesciences located?▼
Edwards Lifesciences operates in the Health Care sector.
When did Edwards Lifesciences complete a stock split?▼
The last stock split for Edwards Lifesciences was on June 01, 2020 with a ratio of 3:1.
Where is Edwards Lifesciences headquartered?▼
Edwards Lifesciences is headquartered in Irvine, US.